The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSDI Group Regulatory News (SDI)

Share Price Information for SDI Group (SDI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 69.00
Bid: 68.00
Ask: 70.00
Change: -0.50 (-0.72%)
Spread: 2.00 (2.941%)
Open: 69.00
High: 69.50
Low: 69.00
Prev. Close: 69.50
SDI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Guidance from DoH on contamination levels

26 May 2015 07:01

RNS Number : 1061O
Scientific Digital Imaging Plc
26 May 2015
 

SCIENTIFIC DIGITAL IMAGING PLC

 

Scientific Digital Imaging welcomes guidance from the UK Department of Health on contamination levels on surgical instruments

 

 

Cambridge, UK: Scientific Digital Imaging plc (AIM: SDI, "SDI" or the "Company") the AIM quoted group focused on the application of digital imaging technology for use in life sciences, healthcare, astronomy, and art conservation, welcomes the new guidelines from the UK Department of Health indicating the upper limit of acceptable protein contamination on surgical instruments after processing. Information issued in an updated version of the guidance, to minimise transmission risk of Creutzfeldt-Jakob Disease (CJD) and variant Creutzfeldt-Jakob Disease (vCJD) in healthcare settings*, recommends that the upper limit of acceptable protein contamination after processing to be 5µg BSA equivalent per instrument side, with a lower level necessary for neurosurgical instruments. In addition evidence indicates that the Ninhydrin swab kits, which are commonly used for the testing of cleaned instruments, have shown to be insensitive. Furthermore, proteins are poorly desorbed from instruments by swabbing.

 

Ken Ford, Chairman of SDI commented: 

"We welcome the guidance from the Department of Health on the acceptable level of protein remaining on surgical instruments as well as the evidence on the Ninhydrin swabbing. We have been waiting for some time for guidance on what is a safe and acceptable level of residual protein that can remain on surgical instruments after decontamination and ProReveal, our highly sensitive fluorescence-based patented protein detection test, is the only marketed product of which we are aware that can adhere to these stringent guidelines. It allows the testing of the whole instrument for protein, rather than just a small, swabbed area, and will be invaluable to the Sterile Services Departments in hospitals throughout the UK and the broader market."

 

ProReveal is a highly sensitive fluorescence-based patented protein detection test for checking the presence of residual protein on surgical instruments after going through a washer disinfector process. This cost-effective test (conforms to BS EN ISO 15883-1) delivers objective, visual and measurable results, removing any doubt as to whether the washing decontamination process has left instruments demonstrably clean. Using the powerful diagnostic tools of ProReveal, users can track the performance of their washer disinfector processes and to see whether there are any changes in trends.

 

Taking less than 5 minutes to carry out, ProReveal generates results as a visual display of the presence (or absence) of any protein and these results can be documented and archived as proof of process cleanliness. Promoting this alternative detection method has required a re-education process in Sterile Services Departments (SSDs) in hospitals, where the system is most applicable.

 

-Ends-

 

* https://www.gov.uk/government/publications/guidance-from-the-acdp-tse-risk-management-subgroup-formerly-tse-working-group

 

For Further Information:

 

Scientific Digital Imaging plc - 01223 727144

Mike Creedon, Chief Executive - 07872 402066

Ken Ford, Chairman - 07884 313191

 

finnCap - 020 7220 0500

Ed Frisby / Simon Hicks, Corporate Finance

Mia Gardener, Corporate Broking

 

JW Communications

Julia Wilson, Investor & Public Relations - 07818 430877

 

 

Note to Editors:

 

 

About Scientific Digital Imaging plc

 

Scientific Digital Imaging plc designs, manufactures and sells digital imaging technology for use in the life sciences, healthcare, astronomy, and art conservation through Synoptics brands (Syngene, Synoptics Health, Synbiosis and Syncroscopy), the Artemis CCD company brands (Atik Cameras and Artemis CCD Cameras) and the Opus Instruments brand (Osiris). SDI plans to continue to grow through its own technology advancements as well as strategic, complementary acquisitions.

 

www.scientificdigitalimaging.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAATMITMBTTBLA
Date   Source Headline
19th Jan 20217:00 amRNSExercise of Options and Total Voting Rights
13th Jan 20215:20 pmRNSExercise of Options and Total Voting Rights
12th Jan 20217:23 amRNSProgressive publishes new research
5th Jan 20217:00 amRNSExercise of Options and Total Voting Rights
10th Dec 202010:20 amRNSDirector Dealing
10th Dec 20207:00 amRNSInvestor Presentation
9th Dec 20207:00 amRNSInterim Results
7th Dec 202011:06 amRNSSecond Price Monitoring Extn
7th Dec 202011:01 amRNSPrice Monitoring Extension
3rd Dec 20207:00 amRNSAcquisition of Monmouth Scientific Limited & TVR
26th Nov 20204:50 pmRNSExercise of Options and Total Voting Rights
28th Oct 20202:23 pmRNSChange of Website
22nd Oct 20207:00 amRNSTrading Update
23rd Sep 20202:06 pmRNSSecond Price Monitoring Extn
23rd Sep 20202:00 pmRNSPrice Monitoring Extension
23rd Sep 202011:40 amRNSResult of AGM
23rd Sep 20207:00 amRNSAGM Trading Update & Investor Meet Company Q&A
3rd Sep 20204:24 pmRNSExercise of Options and Total Voting Rights
26th Aug 20204:49 pmRNSPosting of AR&A and Notice of AGM - Replacement
26th Aug 20204:11 pmRNSPosting of AR&A and Notice of AGM
17th Aug 20204:36 pmRNSPrice Monitoring Extension
21st Jul 20202:06 pmRNSSecond Price Monitoring Extn
21st Jul 20202:00 pmRNSPrice Monitoring Extension
21st Jul 202010:51 amRNSDirector Dealing
21st Jul 20207:01 amRNSInvestor Presentation
21st Jul 20207:00 amRNSFinal Results
9th Jul 20207:00 amRNSNotice of Results
26th May 20202:06 pmRNSSecond Price Monitoring Extn
26th May 20202:00 pmRNSPrice Monitoring Extension
23rd Apr 20207:00 amRNSTrading & COVID-19 Update
20th Mar 20207:00 amRNSDirector/PDMR Shareholding
9th Mar 20203:10 pmRNSHolding(s) in Company
31st Jan 20201:19 pmRNSHolding(s) in Company
24th Jan 20203:29 pmRNSExercise of Options
27th Dec 20199:30 amRNSHolding(s) in Company
19th Dec 20191:14 pmRNSDirector/PDMR Shareholding
17th Dec 20197:00 amRNSInterim Results
2nd Dec 20197:00 amRNSAcquisition
31st Oct 20197:00 amRNSChange of Name
9th Oct 201910:43 amRNSExercise of Options
25th Sep 20194:55 pmRNSResult of AGM
25th Sep 20197:00 amRNSAGM Trading Update
20th Sep 20191:15 pmRNSDate of Annual General Meeting
3rd Sep 20195:46 pmRNSPosting of Annual Report and Notice of AGM
22nd Jul 20197:04 amRNSDirector/PDMR Shareholding
18th Jul 20197:00 amRNSFinal Results
27th Jun 20197:00 amRNSTrading Update
15th May 20197:00 amRNSTrading Update
9th May 20197:00 amRNSSDI to present at Mello 2019
5th Apr 201911:02 amRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.